This study explains the mechanism by which severe anemia occurs in SF3B1 mutant MDS patients and identifies a direct role for MAP3K7 in the proper regulation of erythroid differentiation, leading to further prevention of anemia (41). This evidence concerns the gene MAP3K7 and myelodysplastic syndrome.